I'm curious, what was your impetus for buying at this point ($14.75) in time with the uncertainty surrounding competitive approval of 20 mg and 40 mg dose(s) as suggested by Mylan?
First I think RVNC will drop again so I sold. I have been playing back andfourth between MNTA and RNVC since MNTA went to 8.50 last year and have did great. MNTA. Has a lot going in with very little down side. Which ever stock seems like the best deal i move there. I also believe 40mg will happen sooner then what seems to be the common thread here. Just a hunch. Best of luck to you